Ohtani H, Fukushi Y, Orikasa S, Nagura H
Department of Pathology II, Tohoku University School of Medicine, Sendai, Japan.
J Histochem Cytochem. 1991 Apr;39(4):479-84. doi: 10.1177/39.4.1672317.
Renal cell carcinomas are immunohistochemically positive for oligosaccharides with the Le(x) determinant (Gal beta 1----4[Fuc alpha 1----3]GlcNAc) and its derivatives, as oncofetal antigens, and their expression is closely related to a better prognosis of the patients. This study was designed to clarify the difference in antigen localization at the ultrastructural level between renal cell carcinoma and normal tissues. In normal kidneys, Le(x) detected by monoclonal antibody (MAb) FH 2 and sialylated extended Le(x) (sialyl Le(x)-i) by MAb FH 6 were identified along the plasma membrane of microvilli of proximal tubule epithelial cells, with occasional immunoreactivity along the basolateral plasma membranes. Intracellular localization was very sparse. Renal cell carcinoma showed localization of Le(x) and sialyl Le(x)-i antigens along the cell membrane and in the cytosol as aggregates or filaments. Immunoreactive materials were also observed in the lumen formed among carcinoma cells. The cytosolic immunoreactivity, not observed in the normal kidney, was regarded as "abnormal cytosolic accumulation" of the antigens. This pattern was more pronounced in clear-cell carcinoma. Pretreatment of specimens with chloroform-methanol, which extracts glycolipids, decreased immunoreactivity in carcinoma tissues, particularly that in the cytosol. The extracts contained substances immunoreactive for MAb FH6. Our study has demonstrated that (a) remarkable changes occur in the ultrastructural localization patterns of sialyl Le(x)-i and Le(x) in renal cell carcinoma and (b) considerable amounts of glycolipids are contained in the substances with sialyl Le(x)-i deposited in the cytosol of clear-cell carcinoma.
肾细胞癌对具有Le(x)决定簇(Galβ1----4[Fucα1----3]GlcNAc)及其衍生物的寡糖呈免疫组化阳性,这些寡糖作为癌胚抗原,其表达与患者较好的预后密切相关。本研究旨在阐明肾细胞癌与正常组织在超微结构水平上抗原定位的差异。在正常肾脏中,用单克隆抗体(MAb)FH 2检测到的Le(x)以及用MAb FH 6检测到的唾液酸化延伸Le(x)(唾液酸化Le(x)-i)在近端小管上皮细胞微绒毛的质膜上被识别,偶尔在基底外侧质膜上也有免疫反应性。细胞内定位非常稀少。肾细胞癌显示Le(x)和唾液酸化Le(x)-i抗原沿细胞膜以及在胞质溶胶中呈聚集或丝状定位。在癌细胞之间形成的管腔中也观察到免疫反应性物质。在正常肾脏中未观察到的胞质免疫反应性被视为抗原的“异常胞质积累”。这种模式在透明细胞癌中更为明显。用氯仿 - 甲醇预处理标本(可提取糖脂)可降低癌组织中的免疫反应性,尤其是胞质溶胶中的免疫反应性。提取物中含有对MAb FH6有免疫反应性的物质。我们的研究表明:(a)肾细胞癌中唾液酸化Le(x)-i和Le(x)的超微结构定位模式发生了显著变化;(b)在透明细胞癌胞质溶胶中沉积的含有唾液酸化Le(x)-i的物质中含有大量糖脂。